Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT03083132 · ClinicalTrials.gov registry record · Phase 2
Modafinil for Freezing of Gait (FOG) in Parkinson's Disease (PD)
A Phase 2 study, sponsored by University of Arkansas.
- Completed
- Registry status
- Phase 2
- Development phase
- 21
- Enrollment target
NCT03083132 is a Phase 2 study that has completed, run by University of Arkansas. The registered enrollment target is 21 participants.
The verdict
NCT03083132, a Phase 2 study, has completed, sponsored by University of Arkansas.
- COMPLETED
- Registry status
- Phase 2
- Development phase
- 21 participants
- Enrollment target
Study Summary
Freezing of gait is a late stage complication of Parkinson's disease in which patients note that their feet feel stuck or glued to the ground. This can lead to imbalance and falls and the secondary complications that can result from falls such as fractures and hospitalizations. While levodopa can help freezing of gait in some patients, it does not help in all, and the dose needed to treat freezing may be limited by side effects of the medications. Currently there are no treatments targeted towards freezing of gait and the goal of this research is to see if Modafinil could be one such drug to help freezing of gait in Parkinson's disease.
Interventions
- DRUG Placebo oral capsule
- DRUG modafinil 50mg
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 21 participants |
| Start Date | 2017-06-13 |
| Est. Completion | 2019-11-12 |
| Phase | Phase 2 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT03083132
The ClinicalTrials.gov registry entry for NCT03083132 describes a study currently listed as completed, categorized as Phase 2. The registered enrollment target is 21 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is University of Arkansas, which has 318 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 2 interventions - of which Placebo oral capsule is the first listed.
NCT03083132 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT03083132 about?
NCT03083132 is a clinical study titled "Modafinil for Freezing of Gait (FOG) in Parkinson's Disease (PD)". Freezing of gait is a late stage complication of Parkinson's disease in which patients note that their feet feel stuck or glued to the ground. This can lead to imbalance and falls and the secondary complications that can result from falls such as fractures and hospitalizations. While levodopa can he...
What is the current status of trial NCT03083132?
This trial is currently completed. It is a Phase 2 study. The enrollment target is 21 participants. The study started on 2017-06-13. Estimated completion is 2019-11-12.
What interventions are being tested in trial NCT03083132?
The interventions under investigation include: Placebo oral capsule (DRUG), modafinil 50mg (DRUG).
Who is sponsoring clinical trial NCT03083132?
This trial is sponsored by University of Arkansas, which has 318 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.